Alexis E. Shafii, MD

Dr. Alexis Shafii is a cardiothoracic surgeon with expertise in thoracic transplantation and adult cardiac surgery. Show full bio

His clinical focus includes thoracic organ failure, heart and lung transplantation as well as implantation of mechanical circulatory support devices. He is the surgical director of the heart transplant program at Baylor St. Luke’s Medical Center, and previously directed transplant programs at major medical centers in Dallas and Kentucky.

Dr. Shafii also treats adult acquired cardiac diseases, including coronary artery disease, heart valve disease, and aortic pathologies. His research efforts focus on heart and lung transplantation, ventricular assist devices, and extracorporeal membrane oxygenation (ECMO).

See Publications


  • Heart and Lung Transplant
  • Cardiac Surgery


  • Undergraduate:

    Boston College

  • Medical School:

    University of South Florida College of Medicine

  • Residency:

    University of South Florida College of Medicine

  • Fellowships:

    Cleveland Clinic Foundation


  • American Board of Surgery
  • American Board of Thoracic Surgery

Honors, Awards and Memberships


Allen, S. R., Slaughter, M. S., Ahmed, M. M. et al. (2022). COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant, S1053-2498(22)02180–5.
Inchaustegui, C. A., Patel, A., Lamba, H. K. et al. (2022). Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs.
Akkanti, B., Suarez, E. E., O’Neil, E. R. et al. (2022). Extracorporeal membrane oxygenation for COVID-19: Collaborative experience from the Texas Medical Center in Houston with 2 years follow-up. ASAIO J.
Chatterjee, S., Loor, G., Shafii, A. E. et al. (2022). Commentary: Get up and go! Pushing the envelope in ambulatory extracorporeal membrane oxygenation. JTCVS Tech 13, 135–136.
Lamba, H. K., Parikh, U. M., Vincent, J. et al. (2022). Preoperative hyponatremia and survival after left ventricular assist device implantation. Artif Organs.
Shafii, A., Liao, K. and Ghanta, R. K. (2021). Commentary: Guidance during uncertain times: Navigating the HeartWare HVAD recall. J Thorac Cardiovasc Surg, S0022-5223(21)01710–4.
Loor, G., Chatterjee, S. and Shafii, A. (2021). Extracorporeal membrane oxygenation support before lung transplant: A bridge over troubled water. JTCVS Open 8, 147–154.
Parikh, U., Lamba, H., Ajmal, M. et al. (2021). Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs 24, 207–216.
Lamba, H. K., Kim, M., Santiago, A. et al. (2021). Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs.
Galvan, N. T. N., Moreno, N. F., Garza, J. E. et al. (2020). Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant 20, 3113–3122.

Recent News

The Texas Heart Institute Makes a Strong Showing at ISHLT 2023

Daniel Timms, PhD, founder and chief technical officer of BiVACOR, Inc., described the benchtop testing and preclinical studies performed with...

Sharing Our Latest Research With the World

Our Professional Staff members have demonstrated a commitment to advancing cardiovascular science. This can be seen in their research output....

How the Texas Medical Center’s Extracorporeal Membrane Oxygenation Specialists Teamed Up to Save Lives During the COVID Crisis

From the early stages of the COVID-19 pandemic, critical care medicine professionals on clinical teams across the Texas Medical Center...